Child-Pugh scoreMELD scoreThere are an increasing number of studies that evaluate predictive factors, mostly of death, in cirrhosis. These are different depending on the presence of compensated or decompensated cirrhosis. In compensated cirrhosis the main event to predict is decompensation. The degree...
Short term and medium term survival predictive value of the Child-Turcotte-Pugh (CTP) and Model for End Stage Liver Disease (MELD) score has been established but their usefulness in predicting survival of hospitalized patients with decompensated cirrhosis is lacking. We compared the survival predictiv...
Decompensated cirrhosis is defined as stage 4 liver fibrosis with the presence of one or several complications of portal hypertension including variceal bleeding, hepatic encephalopathy, ascites, spontaneous bacterial peritonitis (SBP), and/or hepatorenal syndrome. ...
8.Child-Pugh's Score in Prediction of Prognosis of Patients with Decompensated Liver CirrhosisChild-Pugh分级对失代偿期肝硬化预后的评估 9.Analysis of Prognosis in Patients with Decompensated Cirrhosis by the Model for End-stage Liver Disease and Its Longitudinal Modifications;终末期肝病模型及其变化对失...
We analyzed the outcome of lamivudine treatment in 23 consecutive patients with severely decompensated HBV-cirrhosis defined as a Child-Pugh-Turcotte (CPT) score of ≥10, and compared with a historical untreated control group of 23 patients matched for age, gender, and baseline CPT score. ...
No MI was associated with final Child–Pugh score ≤ 6 (p = 0.030) or final Child–Pugh class A (p = 0.020). Conclusions Chronic treatment with simvastatin 40 mg/day in patients with decompensated cirrhosis was associated with several adverse events, being MI the only clinically significant ...
∗Including patients with decompensated cirrhosis. n.s., no specified platelet lower limit. wk, weeks; G, genotype; CTP, Child-Pugh; SVR12, sustained virologic response 12 weeks after the end of treatment; SVR24, sustained virologic response 24 weeks after the end of treatment. For genotype...
Although entecavir has been shown to improve health outcomes in a cost-effective manner in mixed populations of CHB patients, the cost-effectiveness of entecavir has not been evaluated in CHB patients with decompensated cirrhosis. Methods: This study assessed the cost-effectiveness of entecavir versus...
Prognostic evaluation for patients with decompensated hepatic cirrhosis Objective: To compare the value between MELD score and Child - Pugh classification in determining the shortterm prognosis of patients with hepatic cirrhosi... CM Jiang,W Xie,ZH Wang - 《Journal of Dalian Medical University》 被...
9.Child-Pugh's Score in Prediction of Prognosis of Patients with Decompensated Liver CirrhosisChild-Pugh分级对失代偿期肝硬化预后的评估 10.Analysis of Prognosis in Patients with Decompensated Cirrhosis by the Model for End-stage Liver Disease and Its Longitudinal Modifications;终末期肝病模型及其变化对失...